Programmed death 1 (PD-1) and ligand (PD-L1) inhibitors in head and neck squamous cell carcinoma: A meta-analysis.

Dylan A Levy,Jaimin J Patel,Shaun A Nguyen,W Nicholas Jungbauer,David M Neskey,Ezra E W Cohen,Chrystal M Paulos,John A Kaczmar,Hannah M Knochelmann,Terry A Day

World journal of otorhinolaryngology - head and neck surgery（2022）

引用 0|浏览2

暂无评分

摘要

Meta-analysis shows the efficacy of PD-1 and PD-L1 inhibitors in HNSCC and suggests a possible difference in certain RECIST criterion between PD-1 and PD-L1 inhibitors. Future work to investigate the clinical significance of these findings is warranted.

查看译文

关键词

antibodies,disease progression,head and neck neoplasms,humanized,meta‐analysis,monoclonal,squamous cell carcinoma of the neck

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要